1999
DOI: 10.1016/s0092-8674(00)81010-7
|View full text |Cite
|
Sign up to set email alerts
|

Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis

Abstract: Vascular endothelial cadherin, VE-cadherin, mediates adhesion between endothelial cells and may affect vascular morphogenesis via intracellular signaling, but the nature of these signals remains unknown. Here, targeted inactivation (VEC-/-) or truncation of the beta-catenin-binding cytosolic domain (VECdeltaC/deltaC) of the VE-cadherin gene was found not to affect assembly of endothelial cells in vascular plexi, but to impair their subsequent remodeling and maturation, causing lethality at 9.5 days of gestatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

50
1,008
3
14

Year Published

2000
2000
2008
2008

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 1,162 publications
(1,075 citation statements)
references
References 39 publications
50
1,008
3
14
Order By: Relevance
“…Strikingly, this group showed that morpholino knockdown of VE-cadherin expression selectively prevented tumor cell-induced angiogenesis by FGF2, but not normal vessel development including formation of the intersegmental and subintestinal vessels. These findings are surprising in light of the fact that VE-cadherin null mice display several vascular defects in vessel assembly that cause embryonic lethality at day 9.5 (Carmeliet et al, 1999). The apparent discrepancy in these studies may be due to differences in the vascular programs utilized by fish and mammals.…”
Section: Early Embryo Xenotransplantant Modelmentioning
confidence: 93%
“…Strikingly, this group showed that morpholino knockdown of VE-cadherin expression selectively prevented tumor cell-induced angiogenesis by FGF2, but not normal vessel development including formation of the intersegmental and subintestinal vessels. These findings are surprising in light of the fact that VE-cadherin null mice display several vascular defects in vessel assembly that cause embryonic lethality at day 9.5 (Carmeliet et al, 1999). The apparent discrepancy in these studies may be due to differences in the vascular programs utilized by fish and mammals.…”
Section: Early Embryo Xenotransplantant Modelmentioning
confidence: 93%
“…(Larue et al, 1994) VE-cadherin Cell-cell adhesion Total Death at E9.5, endothelial cells are assembled in vascular plexi, but their subsequent remodeling and maturation are impaired. (Carmeliet et al, 1999) L1-CAM Cell-cell adhesion Total Malformations of the nervous system, decreased nerve sensitivity, weak and uncoordinated hindlegs. (Dahme et al, 1997) Ate1 Arginyltransferase Total Embryonic lethality at E12-17 with defects in cardiovascular development and angiogenesis (Kwon et al, 2002) Calpain IV (Capn4) Protease Total Embryonic lethality at midgestation with defects in the cardiovascular system, (Arthur et al, 2000) Birth Defects Res C Embryo Today.…”
Section: Note On Nomenclaturementioning
confidence: 99%
“…The adherens junctional molecules, vascular endothelial cadherin (VE-cadherin) and β-catenin are important for formation of continuous monolayers, regulation of vascular permeability, endothelial survival, tubulogenesis and initiation of angiogenesis [7,8,9]. They play a key role in placental vascular development in humans, as shown by the early expression of these molecules in haemangioblasts of the first trimester placenta [10].…”
Section: Introductionmentioning
confidence: 99%